Skip to main content
. 2012 Aug;342(2):461–471. doi: 10.1124/jpet.112.194464

Fig. 4.

Fig. 4.

A and B, effect of the glycine/NMDAR antagonist R-(+)-HA-966 (10 mg/kg i.v.) or saline (vehicle) on intravenous NMDA-evoked changes in ΔMAP (A) and heart rate (ΔHR) (B) in conscious male Sprague-Dawley rats. C and D, effect of R-(+)-HA-966 or saline, given alone, on ΔMAP (C) and ΔHR (D). Values are means ± S.E.M. of four to six observations. #, P < 0.05 versus NMDA.